Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
NCT06940830
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia A
Interventions
DRUG:
Efanesoctocog alfa
Sponsor
Swedish Orphan Biovitrum
Collaborators
[object Object]